SCIEX Builds on Cadence of Innovation in Biopharma With Biologics Explorer
New application software enables protein
characterization analysis for the ZenoTOF 7600 system
SCIEX, a global leader in life science analytical technologies
and Danaher operating company, launches Biologics Explorer
software, enabling customers to acquire insights from their
high-resolution protein characterization data, and reach decisions
quickly and confidently on the most important critical quality
attributes for biopharmaceuticals. Biologics Explorer signifies the
next step in innovation, building upon the ZenoTOF 7600 system,
alongside Molecule Profiler.
To bring life-saving protein therapeutics to market safely and
rapidly, it is critical to fully characterize candidate molecules
at every stage of development. Biologics Explorer allows scientists
to harness the full potential of the incredibly rich spectra
produced from the Zeno trap and electron activated dissociation
(EAD), from the ZenoTOF 7600 system, into highly informative and
actionable results. These results are based upon a nodal algorithm
structure that enables each processing and analysis step to be
optimized so scientists can get the clear answers they need from
“The launch of the ZenoTOF 7600 system is the beginning of new
possibilities for biopharmaceutical scientists and sets the pace
for a cadence of innovation,” said Mani Krishnan, VP GM, CE &
Biopharma at SCIEX. “While Molecule Profiler extended the ZenoTOF
7600 system’s capabilities into oligonucleotides, Biologics
Explorer extends the reach once more, this time into protein
therapeutics. Together, the ZenoTOF 7600 system with these new
software applications will provide fresh and deeper insights for
biologic manufacturers, allowing them to rapidly progress their
therapies through the pipeline.”
The strategic software partnership between SCIEX and Genedata
allows for this expansion of functionality. Biologics Explorer is
built upon Genedata Expressionist®, industry-leading enterprise
software platform for biopharmaceutical mass spectrometry.
“I am delighted to see the value delivered by our software
platform as an out-of-the-box desktop solution addressing the
specific needs of SCIEX customers. Partnerships like this help to
deliver new capabilities to the wider biopharma community and
enable the opportunity for an enterprise implementation with
Genedata Expressionist where required,” said Othmar Pfannes, Ph.D.,
CEO of Genedata.
Currently available workflows include intact and subunit
analysis, PTM determination and MAM, peptide mapping by EAD or CID
and disulfide bond analysis.
To learn more about the Biologics Explorer and other software
offerings, visit here.
SCIEX delivers solutions for the precision detection and
quantification of molecules, empowering our customers to protect
and advance the wellness and safety of all. We have led the field
of mass spectrometry for 50 years. From the launch of the first
ever commercially successful triple quadrupole in 1981, we have
developed groundbreaking technologies and solutions that influence
life-changing research and outcomes.
Today, as part of the Danaher (NYSE: DHR) family of global
science and technology innovators, we continue to pioneer robust
solutions in mass spectrometry and capillary electrophoresis. Our
customers are able to quickly respond to environmental hazards,
better understand biomarkers relevant to disease, improve patient
care in the clinic, bring relevant drugs to market faster and keep
food healthier and safer.
That’s why thousands of life science experts around the world
choose SCIEX to get the answers they can trust to better inform
critical decisions that positively impact lives.
For more information, visit sciex.com.
Let’s connect: Twitter, LinkedIn, Facebook, and Instagram.
Advances in human wellness depend on the power of precise
The SCIEX clinical diagnostic portfolio is For In Vitro
Diagnostic Use. Rx Only. Product(s) not available in all countries.
For information on availability, please contact your local sales
representative or refer to www.sciex.com/diagnostics. All other
products are For Research Use Only. Not for use in Diagnostic
Trademarks and/or registered trademarks mentioned herein,
including associated logos, are the property of AB Sciex Pte. Ltd.
or their respective owners in the United States and/or certain
other countries (see www.sciex.com/trademarks).
© 2021 DH Tech. Dev. Pte. Ltd. RUO-MKT-12-13757-A.
version on businesswire.com: https://www.businesswire.com/news/home/20210901005698/en/
Lulu VanZandt Manager, Brand, Public Relations and Social Media,
SCIEX firstname.lastname@example.org +1 (508) 383-7163 M: +1 (508)
Historical Stock Chart
From Sep 2021 to Oct 2021
Historical Stock Chart
From Oct 2020 to Oct 2021